logo
The brain has a secret survival trick to endure a marathon

The brain has a secret survival trick to endure a marathon

A study of long-distance runners shows the brain's remarkable ability to adapt—by burning its own fat. A marathon taxes more than just muscles—it pushes the brain to its metabolic limits. New research shows that during extreme endurance events, the brain may burn its own fat for fuel, revealing just how adaptable—and surprising—the mind can be. Photograph by Ben Stansall, AFP/Getty Images
Carlos Matute wasn't looking for a scientific breakthrough when he laced up his shoes for a long run. But as the miles ticked by, the neuroscientist from the University of the Basque Country found himself chasing a persistent question: 'How do we make it to the finish line, being conscious, after having our energy stores depleted?'
That curiosity led to a surprising possible answer. In a recent study in Nature Metabolism, Matute found that myelin—the fatty insulation wrapped about nerve fibers—provides energy when fuel runs low, such as during a grueling endurance event like a marathon. Some headlines have sensationalized the finding as the brain 'eating itself,' but Matute says the truth is far more nuanced—and promising. Instead, it adds evidence of how the brain adapts and changes, even well into adulthood. Your brain burns fat during a marathon
For his study, Matute and colleagues scanned the brains of 10 recreational runners using MRI before and after a marathon, and again two weeks to two months later. In the two days post-marathon, myelin was reduced in 12 of the 100 areas evaluated; the affected areas were involved in motor coordination, sensory integration, and emotion, regions frequently used during running. Two months after the marathon, myelin levels recovered.
(This is why running is the ultimate cardiovascular sport.)
The team determined the results were not due to dehydration. Instead, it seems that the brain is using myelin, which is mostly lipids or 'brain fat' as Matute calls it, as fuel. 'When there is no glucose coming from the bloodstream, then [the brain] has to use whatever it has at hand,' says Matute. For a neuron, this means myelin.
Participants ranged in age from 45 to 73, suggesting that even older brains remain remarkably adaptable. 'Nobody foresaw that this would happen, that the structure of our brain may change so rapidly, in the time which it takes you to run the marathon,' says Matute.
Matute doesn't believe the temporary drop in myelin leads to noticeable cognitive changes. He suspects the brain routinely taps into myelin for fuel, just at levels too low to detect—except during extreme events like a marathon.
But there's no need to panic, he says. The changes were short-lived—and may even be healthy. 'You exercise everything, including your myelin metabolism,' he says. What running does to your brain
Running has long been linked to brain benefits. It boosts mood-regulating chemicals like dopamine, serotonin, and norepinephrine, which can ease anxiety and depression. That famous 'runner's high,' once chalked up to endorphins, may come from endocannabinoids—the brain's natural version of cannabis.
(Here's how to get high on your hormones—naturally.)
Aerobic exercise also seems to spur the birth of new neurons in the hippocampus, the brain region critical for memory and learning. Over time, these changes may protect against cognitive decline.
Marathon running has been studied less than running in general, but some studies show these trends hold up over 26 miles. One study reported that some regions of the hippocampus were larger in marathon runners than in healthy controls. Astrid Roeh, a physician at the University of Augsburg, found that marathon runners exhibited fewer depressive symptoms than sedentary people over six months and reported the best moods the day after the marathon.
(Humans were built for long-distance running.)
In another study, Roeh found that marathon running led to changes in the brain's electrical activity, as measured by electroencephalogram (EEG). Like Matute's findings in myelin, these changes were transient. 'The changes in EEG patterns indicate that there are alterations in how neural circuits are functioning and communicating,' she says.
This reorganization in response to experience is called neuroplasticity. She hypothesizes that regular physical activity may prime the brain for plasticity. 'If someone is already physically active, then intense challenges like a marathon might have a stronger — or at least more coordinated — neuroplastic effect,' she says. 'The system is ready to respond more effectively.'
However, not all brain changes are positive. Marathoners and endurance athletes are particularly prone to overtraining syndrome, says Luana Main, a professor at Deakin University. 'A lot of endurance athletes are still of the mindset that more is always better,' she says. But doing more without sufficient rest, especially when sick or stressed, taxes the body too much.
Overtraining syndrome leads to injury and poor performance and can take months or years to recover from. It also affects the brain. 'Changes in mood state are often one of the first changes that occur before you see a decrement in performance,' says Main. Overtrained athletes tend to feel grumpy, overwhelmed, and tired. 'They're just not loving life,' she says.
(No time to exercise? Just five minutes still has a big impact.)
In a review, Main and her colleagues found that cognitive function, particularly reaction time, was impaired when athletes were overreaching or overtraining. Main says that because cognition is affected, people are more likely to make errors and become injured.
Paying attention to these cognitive effects can be helpful. In a different review of the research, Main and colleagues found that subjective measures, such as mood and perceived stress, were more sensitive to increased training loads than objective measures, such as heart rate and oxygen consumption. By tracking reaction times with online games and moods with daily journaling, athletes can know when they may be overdoing it.
Avoiding overtraining requires incorporating adequate rest and recovery into training. Main emphasizes that risk is not a reason to avoid exercise; however, the numerous benefits of exercise outweigh the bad. But, for the small part of the population doing huge training loads, 'More is not always better,' she says. 'Sometimes less is more.'
Matute agrees. 'For people who worry, 'Should I stop running?' I would say, 'No, never, as long as you train properly.''

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Jonathan Gluck Was Told His Cancer Was a Death Sentence. 22 Years Later, He Shares How Science Saved Him (Exclusive)
Jonathan Gluck Was Told His Cancer Was a Death Sentence. 22 Years Later, He Shares How Science Saved Him (Exclusive)

Yahoo

timean hour ago

  • Yahoo

Jonathan Gluck Was Told His Cancer Was a Death Sentence. 22 Years Later, He Shares How Science Saved Him (Exclusive)

In 2003, writer and editor Jonathan Gluck was diagnosed with an incurable blood cancer He was 38 — and a new dad — and told he had less than three years to live Advancements in cancer treatments have kept him alive for more than two decades, he writes in his new memoir, An Exercise in Uncertainty: A Memoir of Illness and Hope In April, when Jonathan Gluck turned 60, friends urged him to mark the milestone with a blowout event. After all, 'no one was sure I'd reach 60,' he says. But the writer and former managing editor of Vogue magazine wasn't interested: 'I was like, 'I don't want to tempt the fates.' ' After being diagnosed with multiple myeloma, an incurable blood cancer that develops in the bone marrow and damages bones and the immune system, at the age of 38, Gluck knows he's already outlived his predicted expiry date by 20 years. But the truth is, he did want to celebrate, in his own quiet way. So, he, his wife, Didi, and their 17-year-old son flew from their New York City home to Ohio to visit their daughter at college — and they had a birthday dinner in the school cafeteria. On the menu: a 'throwback to the '70s' salad bar and chocolate chip pretzel cookies. 'I couldn't have been happier,' he says. 'It was about being together, the four of us.' Finding joy in the day-to-day has been one of the 'strange gifts' of Gluck's life with cancer. 'It comes naturally,' says the writer, whose new memoir An Exercise in Uncertainty: A Memoir of Illness and Hope chronicles how he learned to accept living with an incurable disease and examines the remarkable developments in cancer treatment that have kept him alive. 'When you receive a serious diagnosis, you're forced to think about death a lot more than most people, which is awful in a lot of ways,' he says. 'But there's a sense of urgency to everything for me that I think is useful to anyone. It inspired me to make the most of my time, whether that's with my kids, my career, my friends, or my marriage." In 2003, Gluck was a rising star in the New York publishing world, and he felt like he had it all. A veteran of Men's Health, He'd just been hired as deputy editor of New York magazine—and better still, he and his wife, fellow journalist Didi Gluck, had welcomed their first child, a daughter named Abigail Juliana. When A.J., as they called her, was seven months old, Gluck went to a doctor about a stabbing pain in his hip that had been bothering him for a year after falling on a patch of ice. Worst case, he figured, he'd need hip surgery. But his MRI results delivered a more shocking blow: cancer. After a battery of tests, he learned he was facing multiple myeloma, a blood cancer with recurring tumors that eat away at bone marrow, and which at the time carried a life expectancy of less than three years. Gluck was told he might not survive more than 18 months. 'The minute I heard the news, it was like, game over,' Gluck recalls. He started radiation, had his stem cells harvested — and was elated when he went into remission. But then he began a now-familiar wait for the next sign of trouble. 'Living with an incurable disease is like sleeping next to a hibernating bear,' Gluck writes. 'For the moment, I felt safe, but I knew it was only a matter of time before the bear woke up.' Distraction became a refuge: He threw himself into work, and over the years has discovered Zen-like healing in fly-fishing. 'Your mind tends to not go to all the scary, dark places,' says Gluck of the meditative rhythm of casting a line, which he's been known to practice on his NYC neighborhood street. With an infant at home, he also poured himself into parenting. 'My single greatest fear was, 'Am I going to miss out on being a dad?'' he says. 'Time with A.J. helped not only keep my mind off of bad things, but put my mind on good things.' Just before Gluck hit his three-year mark in remission, he and Didi decided to try for a second child. "My wife has been extremely optimistic throughout this whole process and that was one of the most optimistic moments in her," Gluck says, "She helped lead us through, because she didn't hesitate for a split second. She was like, 'It's going to be okay one way or the other. We're having a second kid.' " But in 2007, four months before their son Oscar was born, Gluck cracked a rib while turning around in his chair at work. Another tumor. Another cycle of radiation, just as he and Didi, now 54, were preparing for their son. Two years later, scans revealed more lesions. From that point forward, it was as if his doctors were playing 'whack-a-mole,' Gluck writes. The relentless strain of illness, caregiving, and the looming possibility of death, took a toll on Gluck's marriage, which by 2013 was nearing a breaking point, culminating in a screaming match on the streets of the East Village. ('We were the couple other people tried not to stare at,' he writes with painful honesty of the fight.) 'It was like we were preparing ourselves for when I was gone,' says Gluck. 'It's difficult to love somebody when you're afraid they might disappear tomorrow. And it's difficult to love somebody when you have tremendous guilt that you're not going to be here for her or our kids.' Therapy helped them find their way back: 'We started to rebuild. We forgave each other.' And they accepted the reality of their dynamic. As Didi once said to him, 'No marriage doesn't have a 'thing'... Cancer is our thing.' Gluck knows there's an odd 'right time/right place' aspect to his cancer. New targeted therapies were developed just as his disease progressed. Some have come with harsh side effects — notably, he writes, uncontrollable diarrhea that caused him to lose 25 pounds and at times saw him dashing from Vogue meetings to the restroom. Other treatments, like CAR T-cell therapy, which genetically modifies a patient's cells to fight cancer, have left his immune system vulnerable. 'I'm slowly getting better, but I'm still living like we all were in the pandemic. I wear a mask in any crowded indoor place. I avoid super crowded places best I can.' But they've bought him precious time. 'Sometimes I walk down the street and shake my head and think, 'How have I survived this?'' he says. "It's not a stretch to say I'm a medical miracle." Nearly two years after his "mind-blowingly futuristic" CAR-T therapy, which he says left him feeling "reborn," Gluck says 'cancer-wise, I'm doing great.' He marvels over the scientific breakthroughs that have saved him each time his cancer returned. At the same time, he's prone to knocking on wood and kissing his knuckles for good measure. 'I've become quite superstitious,' he admits. The disease and treatments have left their marks, however: numbness in his fingers and toes, gastrointestinal problems and bone pain in his hips, spine and neck. He takes six pills, a powder and two liquid medicines daily. And every two months for the rest of his life he needs to get an immunoglobulin infusion to keep his immune system functioning— a procedure that can take up to five hours. It's a small price to pay, he says: 'The moment I was diagnosed, I tried to make a deal with God — 'Just let me see A.J.'s high school graduation.' In my wildest imagination, I didn't think it would happen.' But, as he says, "What better motivation do any of us have than staying alive for our kids?" Last month, he saw A.J. earn her college degree. Next year, his son Oscar will graduate from high school. 'When you're told you might have as little as a year and a half to live and you wind up seeing all these wonderful milestones, you know you're pretty lucky.'Twenty years ago, when Gluck was diagnosed with multiple myeloma, the disease 'was a death sentence,' says Dr. Hearn Jay Cho, chief medical officer with the Multiple Myeloma Research Foundation who is also a clinical professor of medicine at the Icahn School of Medicine at Mt. Sinai and an attending physician with the Multiple Myeloma Service at the Mt. Sinai Tisch Cancer Institute. 'We'd tell people to get their affairs in order because it was bad.'Life expectancy was two to three years. Today, there are 36,000 new cases of myeloma in the U.S., annually, and median survival is about 10 years, with many patients dying of something other than the disease. 'We've made incredible progress,' says drugs Revlimid and Velcade, introduced in 2006-2007, were 'game changers,' he says. 'Before, only about a third of patients had any response to conventional chemotherapy.' With those drugs, 60% to 80% of patients responded, and 'about a third would go into complete remission.' Stem cell transplant therapy and targeted monoclonal antibody drugs like Daratumumab further improved outcomes. Then, in 2021, the FDA first approved CAR T-cell therapy for myeloma, shown to be effective for patients, like Gluck, who'd relapsed after standard therapies.'You can keep patients alive and with good quality of life for a long time,' says Cho, who points out that's due to vital investment in science. 'The job's not done, and we need to finish it. A lot of people are working hard to come up with a cure. Someone like Jon Gluck is alive and kicking today because of medical research.'Read the original article on People

Doctors near HIV cure with ‘previously impossible' discovery: ‘We have never seen anything close to as good'
Doctors near HIV cure with ‘previously impossible' discovery: ‘We have never seen anything close to as good'

New York Post

timean hour ago

  • New York Post

Doctors near HIV cure with ‘previously impossible' discovery: ‘We have never seen anything close to as good'

An estimated 39 million people around the world are living with HIV — and, while treatment options can ensure they have long, healthy lives, there is no known cure. Antiretroviral therapy (ART) — the most effective current treatment — can reduce HIV levels in the body so low the virus is almost undetectable. An estimated 39 million people around the world are living with HIV. dpa/picture alliance via Getty Images However, the fact that the virus can hide in certain white blood cells has been a major hurdle in fully eradicating it. Now, researchers in Australia have developed a novel lipid nanoparticle, dubbed LNP X, capable of delivering mRNA into these elusive cells. Once inside, the mRNA instructs the cells to reveal the concealed virus, potentially allowing the immune system or additional therapies to target and destroy it. Paula Cevaal, research fellow at the Doherty Institute and co-first author of the study, told the Guardian that this remarkable scientific feat was 'previously thought impossible.' 'In the field of biomedicine, many things eventually don't make it into the clinic — that is the unfortunate truth; I don't want to paint a prettier picture than what is the reality,' Cevaal said. Researchers in Australia have developed a novel lipid nanoparticle, dubbed LNP X, capable of delivering mRNA into white blood cells harboring HIV (pictured here). Corona Borealis – 'But in terms of specifically the field of HIV cure, we have never seen anything close to as good as what we are seeing, in terms of how well we are able to reveal this virus,' Cevaal added. 'So from that point of view, we're very hopeful that we are also able to see this type of response in an animal, and that we could eventually do this in humans.' The results were published last week in the journal Nature Communications. While it could take years to get to human clinical trials — the implications are enormous. The findings add to the latest scientific advancements that suggest a cure for HIV could be on the horizon. Last year, researchers in Amsterdam used gene-editing technology to eliminate all traces of the virus from cells in the laboratory. And last July, a 60-year-old German man was declared HIV-free, making him the seventh person to be cured.

'Hidden' breast cancer found in new screening study
'Hidden' breast cancer found in new screening study

Yahoo

time6 hours ago

  • Yahoo

'Hidden' breast cancer found in new screening study

A pioneering breast cancer trial involving more than 9,000 patients has found early stages of the disease that might be missed by regular mammograms. Researchers used a range of different scanning methods, including MRI scans and injecting dye into breast tissue, to better understand the disease. More than 1,300 patients in the trial were recruited through Gloucestershire Hospitals NHS Trust. Dr Sarah Vinnicombe, the lead breast radiologist and deputy director of screening at the Thirlestaine Breast Centre in Cheltenham, said she and her colleagues had known for a long time that mammography "even though it's a good screening tool for most women, is not perfect". The issue, she told BBC Radio Gloucestershire, comes down to the density of breast tissue. People with denser tissue are at a higher risk of developing cancer, but as breast tissue and cancers both appear white on mammograms, early warning signs can be difficult to pick up. The researchers looked at three different ways of picking up early-stage cancers - a whole-breast ultrasound, a quick form of breast MRI and a type of mammogram in which patients are injected with a dye to highlight abnormal areas. With more than 9,000 women involved overall it was the first study ever to take this approach and, Dr Vinnicombe said, it yielded "fascinating" results. What the researchers found in the group of patients who had the MRI scan or contrast mammogram was a "massive increase in the number of cancers" detected. As for how their findings could impact what women are offered, Dr Vinnicombe said: "There are a lot of conversations going on in the Department of Health and the national screening committee at the moment. "It's a work in progress - it's quite clear that we can't just implement contrast mammography or MRI for all those women in the country who have very dense breasts," she added, as this would amount to around 10% of the 2.2 million women screened each year. However, she added, the research had found that not all women with denser breast tissue were at higher risk - meaning the more effective techniques they had identified could be targeted at a smaller group of women. Follow BBC Gloucestershire on Facebook, X and Instagram. Send your story ideas to us on email or via WhatsApp on 0800 313 4630. New hope for patients with breast cancer gene Call for NHS to give women with dense breasts extra cancer scans Gloucestershire NHS Foundation Trust

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store